Shifting from targeted therapies to personalised treatment in chordoma - Authors' reply

Lancet Oncol. 2020 Dec;21(12):e548. doi: 10.1016/S1470-2045(20)30696-3.

Authors

Qi Jia¹, Su Chen¹, Chao Liu¹, Cheng Yang¹, Jianru Xiao²

Affiliations

¹ Department of Orthopedic Oncology, Changzheng Hospital, Navy Medical University, Shanghai 200003, China.
² Department of Orthopedic Oncology, Changzheng Hospital, Navy Medical University, Shanghai 200003, China. Electronic address: [email protected].

PMID: 33271105
DOI: 10.1016/S1470-2045(20)30696-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Chordoma*
Humans
Precision Medicine
Pyridines

Substances

Pyridines
apatinib